Under the continuous increase of policies, China's medical device industry will have broad room for growth

【Pharmaceutical network market analysis】 Medical device industry is a multidisciplinary interdisciplinary, intensive high-tech industry, comprehensive biomedical engineering, electronic information and modern medical imaging and other new technologies, but also to measure a country's comprehensive industrial level of one of the standards, under the huge market demand, the global medical device industry has maintained a good development trend
.

In recent years, China's medical device market has also performed prominently, and the data shows that as of 2020, the size of China's medical device market is about 734.
1 billion yuan, an increase of 18.
3%
year-on-year.

It is estimated that the size of China's medical device market will reach 1,252.
9 billion yuan in 2022, and by 2025, this market size will reach 1,841.
4 billion yuan
.

It is reported that in recent years, in order to make up for the shortcomings of high-end medical equipment, accelerate the research of key core technologies, and break through the bottleneck of technical equipment, the state has successively introduced a series of policies
.

For example, in 2018, the State Food and Drug Administration revised and issued the Special Review Procedure for Innovative Medical Devices; The Regulations on the Supervision and Administration of Medical Devices, which came into effect on June 1, 2021, propose priority review and approval
of innovative medical devices.

As of September 5 this year, the State Food and Drug Administration has approved the registration and listing of 176 innovative medical devices, mainly involving cardiovascular intervention, IVD, medical imaging, peripheral intervention, surgical robots, auxiliary diagnostic software, tumor treatment and other fields
.

With the implementation of the state's policy of encouraging the research and development and production of innovative medical devices, the localization of medical devices and the import substitution policy, China's independent innovative medical devices will accelerate the emergence, and the products will achieve continuous breakthroughs
from the low-end market to the high-end market.

It is reported that in the "Medical Equipment Industry Development Plan (2021-2025)" issued by the Ministry of Industry and Information Technology, it is also proposed that by 2025, 6 to 8 domestic device companies will be promoted to the top
50 in the global medical device industry.

This also means that domestic medical device companies will have broad room
for growth.

At the same time, in the future development, the subdivision mainly based on in vitro diagnostic reagents, orthopedic medical devices, cardiovascular medical devices, medical imaging equipment and high-value consumables may become the focus
of the state's encouragement of development and industry investment.

Data show that at present, there are about 52 enterprises in China's medical device market, among these 52 enterprises, the main business is IVD enterprises, accounting for about 44.
23%, followed by medical medical equipment, accounting for about 23.
08%.


Among these enterprises, Mindray Medical, Xinhua Medical, Dean Diagnostics and Lepu Medical are the first, mindray Medical and Xinhua Medical's main business is medical equipment, Dean Diagnostics is mainly IVD in vitro diagnosis, and Lepu Medical's main business is high-value medical consumables
.

The industry said that with the help of policies, China's medical device track will usher in a golden development cycle
.

In the face of the huge market, the support of the capital market for the medical device track has also continued to heat up, and the domestic medical device industry has been increasing in investment and financing in recent years, and the market activity is relatively high
.

In addition, the author learned that in June 2022, the Shanghai Stock Exchange issued and implemented the "Guidelines for the Application of the Rules for the Review of the Issuance and Listing of the Science and Technology Innovation Board of the Shanghai Stock Exchange No.
7 - Application of the Fifth Set of Listing Standards for Medical Device Enterprises", which also broadened the scope of application of the fifth set of listing standards of the Science and Technology Innovation Board to medical device enterprises
.

The industry said that this will further create a good capital environment
for hard technology medical device companies that have not yet formed a certain income in the research and development stage.

At present, the microelectronic physiology of medical device companies has been listed with the help of the "fifth set of standards on the science and technology innovation board", and in the future, more enterprises will successfully achieve financing
with the help of this listing standard.

Disclaimer: In no event shall the information or opinions expressed herein constitute investment advice
to any person.